CVS Launches Cordavis To Make US Biosimilars More Accessible, Affordable

First Partner Is Sandoz For Adalimumab Product

 
• By Mandy Jackson

CVS Health’s new subsidiary Cordavis will help manufacturers produce and/or commercialize biosimilars with the aim of reducing overall drug costs while improving access to and affordability of medicines.

CVS Health office in Chandler, AZ
CVS will get into biosimilars via subsidiary Cordavis • Source: Shutterstock

More from Drug Pricing

More from Scrip